Literature DB >> 336545

Isolation and properties of complement-resistant strains of Escherichia coli K-12.

Y Akiyama, K Inoue.   

Abstract

Several strains that were resistant to the bactericidal action of antibody and complement were isolated from Escherichia coli K-12 W3110/SM by selecting them through the medium containing antiserum and complement. They can be agglutinated by antiserum against the parent strain and showed similar immune adherence reactivity to the parent when sensitized with this antiserum. Few differences were found in the compositions of phospholipids and proteins between both inner and outer membranes of these strains and those of the parent. However, there were fewer short-chain and more long-chain fatty acids in these strains than in the parent. It was also found that unsaturated fatty acide decreased and saturated and cyclopropanoic acids increased in phosphatidylethanolamine and phosphatidylglycerol in both inner and outer membranes of one of these strains when compared with those from the parent. Therefore, the resistance of these strains to the complement-mediated bactericidal action was considered to be due to the rigidity of their membrane structures which might repel the insertion of membrane-attack complement complex C5b-9, although they could fix the earlier complement components up to the step of the formation of C4b,2a,3b complex enzyme.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 336545      PMCID: PMC421253          DOI: 10.1128/iai.18.2.446-453.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

2.  Genetic control of repression of alkaline phosphatase in E. coli.

Authors:  H ECHOLS; A GAREN; S GAREN; A TORRIANI
Journal:  J Mol Biol       Date:  1961-08       Impact factor: 5.469

3.  Resolution of bacterial proteins by polyacrylamide gel electrophoresis on slabs. Membrane, soluble, and periplasmic fractions.

Authors:  G F Ames
Journal:  J Biol Chem       Date:  1974-01-25       Impact factor: 5.157

4.  Mechanism of cytolysis by complement.

Authors:  M M Mayer
Journal:  Proc Natl Acad Sci U S A       Date:  1972-10       Impact factor: 11.205

5.  Protein composition of the cell wall and cytoplasmic membrane of Escherichia coli.

Authors:  C A Schnaitman
Journal:  J Bacteriol       Date:  1970-11       Impact factor: 3.490

6.  Release of phospholipids from complement-mediated lesions on the surface structure of Escherichia coli.

Authors:  K Inoue; T Kinoshita; M Okada; Y Akiyama
Journal:  J Immunol       Date:  1977-07       Impact factor: 5.422

7.  Chemical studies on damages of Escherichia coli by the immune bactericidal reaction. I. Release and degradation of phospholipids from damaged bacteria.

Authors:  K Inoue; A Takamizawa; K Yano; T Amano
Journal:  Biken J       Date:  1974-12

8.  Chemical studies on damages of Escherichea coli by the immune bactericidal reaction. II. Release of phosphatidylethanolamine from a phospholipase A-deficient mutant of E. coli during the immune bactericidal reaction.

Authors:  K Inoue; K Yano; T Amano
Journal:  Biken J       Date:  1974-12

9.  Phospholipase A-deficient mutants of Escherichia coli B.

Authors:  K Inoue; T Amano
Journal:  Biken J       Date:  1974-12

10.  Release of phospholipids from liposomal model membrane damaged by antibody and complement.

Authors:  T Kinoshita; K Inoue; M Okada; Y Akiyama
Journal:  J Immunol       Date:  1977-07       Impact factor: 5.422

View more
  4 in total

Review 1.  Bactericidal and bacteriolytic activity of serum against gram-negative bacteria.

Authors:  P W Taylor
Journal:  Microbiol Rev       Date:  1983-03

2.  Further characterization of complement resistance conferred on Escherichia coli by the plasmid genes traT of R100 and iss of ColV,I-K94.

Authors:  M M Binns; J Mayden; R P Levine
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441

3.  Importance of complement source in bactericidal activity of human antibody and murine monoclonal antibody to meningococcal group B polysaccharide.

Authors:  W D Zollinger; R E Mandrell
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

4.  Bactericidal activity of human serum against Escherichia coli chi1776.

Authors:  W J Alexander; L S Alexander; R Curtiss
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.